[1] Ostrom QT,Cioffi G,Waite K,et al.CBTRUS Statistical Report:Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018[J].Neuro Oncol,2021,23(12 Suppl 2):iii1~iii105.
[2] Louis DN,Ohgaki H,Wiestler OD,et al.The 2007 WHO classification of tumours of the central nervous system[J].Acta Neuropathol,2007,114(2):97~109.
[3] Desouza RM,Shaweis H,Han C,et al.Has the survival of patients with glioblastoma changed over the years?[J].Br J Cancer,2016,114(2):146~50.
[4] Stupp R,Mason WP,Van Den Bent MJ,et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J].New England journal of medicine,2005,352(10):987~996.
[5] Hsu P,Folkman F,Ghosh S,et al.Actual body weight dosing of temozolomide and overall survival in patients with glioblastoma[J].Journal of Oncology Pharmacy Practice,2021,27(7):1723~1729.
[6] Darnell Jr JE,Kerr LM,Stark GR.Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J].Science,1994,264(5164):1415~1421.
[7] Baumann M,Krause M,Hill R.Exploring the role of cancer stem cells in radioresistance[J].Nature Reviews Cancer,2008,8(7):545~554.
[8] Chang L,Graham P,Hao J,et al.Cancer stem cells and signaling pathways in radioresistance[J].Oncotarget,2016,7(10):11002.
[9] Meraz MA,White JM,Sheehan KC,et al.Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK–STAT signaling pathway[J].Cell,1996,84(3):431~442.
[10]Benekli M,Baer MR,Baumann H,et al.Signal transducer and activator of transcription proteins in leukemias[J].Blood,2003,101(8):2940~54.
[11]Blaszczyk K,Nowicka H,Kostyrko K,et al.The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses[J].Cytokine Growth Factor Rev,2016,29:71~81.
[12]Fleming SB.Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway:Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists[J].Vaccines (Basel),2016,4(3).
[13]Bao S,Wu Q,Mclendon RE,et al.Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J].Nature,2006,444(7120):756~60.
[14]Morgan MA,Canman CE.Replication Stress:An Achilles' Heel of Glioma Cancer Stem-like Cells[J].Cancer Res,2018,78(24):6713~6716.
[15]Ahmed SU,Carruthers R,Gilmour L,et al.Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells[J].Cancer Res,2015,75(20):4416~28.
[16]Ong DST,Hu B,Ho YW,et al.PAF promotes stemness and radioresistance of glioma stem cells[J].Proc Natl Acad Sci U S A,2017,114(43):E9086-E9095.
[17]King HO,Brend T,Payne H L,et al.RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells[J].Stem Cell Reports,2017,8(1):125~139.
[18]Boyd NH,Tran AN,Bernstock JD,et al.Glioma stem cells and their roles within the hypoxic tumor microenvironment[J].Theranostics,2021,11(2):665~683.
[19]Zhang Y,Jin G,Zhang J,et al.Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGFA in human glioma cells[J].Biomed Pharmacother,2018,104:566~575.
[20]Zhan X,Guo S,Li Y,et al.Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation[J].J Exp Med,2020,217(5).
[21]Hua L,Wang G,Wang Z,et al.Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth[J].J Neurooncol,2019,143(1):35~47.
[22]Rycaj K,Tang DG.Cancer stem cells and radioresistance[J].Int J Radiat Biol,2014,90(8):615~21.
[23]Surma-Aho O,NiemelM,Vilkki J,et al.Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients[J].Neurology,2001,56(10):1285~1290.
[24]Alexis F,Pridgen EM,Langer R,et al.Nanoparticle technologies for cancer therapy[J].Handb Exp Pharmacol,2010(197):55~86.
[25]Cook KM,Shen H,Mckelvey KJ,et al.Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas[J].Int J Mol Sci,2021,22(14).
[26]Minea RO,Duc TC,Swenson S D,et al.Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas[J].PLoS One,2020,15(9):e0238238.
[27]Qu S,Guo Y,Huang S-T,et al.Inhibition of STAT1 sensitizes radioresistant nasopharyngeal carcinoma cell line CNE-2R to radiotherapy[J].Oncotarget,2018,9(9):8303.
[28]Knitz MW,Darragh LB,Bickett TE,et al.Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma[J].Cancer Immunology,Immunotherapy,2021:1~13.
[29]Hui Z,Tretiakova M,Zhang Z,et al.Radiosensitization by inhibiting STAT1 in renal cell carcinoma[J].Int J Radiat Oncol Biol Phys,2009,73(1):288~95.
[30]Varikuti S,Oghumu S,Elbaz M,et al.STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade[J].Oncoimmunology,2017,6(11):e1361088.
[31]Raspaglio G,Buttarelli M,Filippetti F,et al.Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels:a new perspective for Parp1 inhibition[J].Cell Death Dis,2021,12(10):933. |
